A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal System

Clinical trial NCT07739589 · COMPLETED

Trial details

NCT number: NCT07739589
Sponsor: Insud Pharma
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Residual Drug Amount of EE and LNG

Start date: 2021-10-25
Primary completion: 2021-11-16
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.